{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-003026","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2022-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.068997+00:00","generated_at":"2026-06-27T08:59:43.729954+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Integrated BioPharma (INBP) Q1 net income $1.0M vs $1.2M; revenue up 2.1%","bullets":["Revenue for quarter ended Dec 31, 2021: $14.6M, up 2.1% YoY from $14.3M.","Operating income fell to $0.7M from $1.2M; net income $1.0M vs $1.2M.","EPS basic unchanged at $0.04; diluted $0.03 vs $0.04.","Six-month revenue down 7.1% to $27.3M; net income $1.5M vs $2.3M.","Co-CEOs attribute 6-month decline to prior year's COVID-related safety stock and demand."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-003026","json":"https://secwatch.observer/filing/0001437749-22-003026.json","markdown":"https://secwatch.observer/filing/0001437749-22-003026.md","text":"https://secwatch.observer/filing/0001437749-22-003026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774922003026/0001437749-22-003026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774922003026/inbp20220209_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T08:59:43.729954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}